ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimide → N-(3-((3,5-Dichloro-N-((4'-fluorobiphenyl-4-yl)methyl)-2-hydroxyphenylsulfonamido) methyl)benzyl)-N-isobutyl-6-(piperidin-1-yl)nicotinamide

HRID 1889682
印刷

反応式

HRID 1889682 の反応式
[Cl:1][C:2]1[C:3]([OH:40])=[C:4]([S:9]([N:12]([CH2:26][C:27]2[CH:32]=[CH:31][C:30]([C:33]3[CH:38]=[CH:37][C:36]([F:39])=[CH:35][CH:34]=3)=[CH:29][CH:28]=2)[CH2:13][C:14]2[CH:19]=[CH:18][CH:17]=[C:16]([CH2:20][NH:21][CH2:22][CH:23]([CH3:25])[CH3:24])[CH:15]=2)(=[O:11])=[O:10])[CH:5]=[C:6]([Cl:8])[CH:7]=1.CCN(C(C)C)C(C)C.[N:50]1([C:56]2[CH:64]=[CH:63][C:59]([C:60]([OH:62])=O)=[CH:58][N:57]=2)[CH2:55][CH2:54][CH2:53][CH2:52][CH2:51]1.CCN=C=NCCCN(C)C.C1C=CC2N(O)N=NC=2C=1>C(#N)C.C(OCC)(=O)C>[Cl:1][C:2]1[C:3]([OH:40])=[C:4]([S:9]([N:12]([CH2:13][C:14]2[CH:15]=[C:16]([CH:17]=[CH:18][CH:19]=2)[CH2:20][N:21]([CH2:22][CH:23]([CH3:25])[CH3:24])[C:60](=[O:62])[C:59]2[CH:63]=[CH:64][C:56]([N:50]3[CH2:51][CH2:52][CH2:53][CH2:54][CH2:55]3)=[N:57][CH:58]=2)[CH2:26][C:27]2[CH:28]=[CH:29][C:30]([C:33]3[CH:34]=[CH:35][C:36]([F:39])=[CH:37][CH:38]=3)=[CH:31][CH:32]=2)(=[O:11])=[O:10])[CH:5]=[C:6]([Cl:8])[CH:7]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

8

反応物 5

HCID 159081-Ethyl-3-(3'-dimethylaminopropyl)carbodiimideHCID 757711-HydroxybenzotriazoleHCID 81531DiisopropylethylamineHCID 27947616-(Piperidin-1-yl)pyridine-3-carboxylic acidHCID 585313773,5-Dichloro-N-((4'-fluorobiphenyl-4-yl)methyl)-2-hydroxy-N-(3-((isobutyl amino)methyl)benzyl)benzene sulfonamide2 回

生成物 1

HCID 58531424
N-(3-((3,5-Dichloro-N-((4'-fluorobiphenyl-4-yl)methyl)-2-hydroxyphenylsulfonamido) methyl)benzyl)-N-isobutyl-6-(piperidin-1-yl)nicotinamide
収率 60%

試薬・触媒・溶媒 2

HCID 6342Acetonitrile溶媒HCID 8857Ethyl Acetate溶媒

実験手順

3,5-Dichloro-N-((4′-fluorobiphenyl-4-yl)methyl)-2-hydroxy-N-(3-((isobutyl amino)methyl)benzyl)benzene sulfonamide (Compound E of Example 184, 0.04 g, 0.066 mmol, 1 eq) was dissolved in acetonitrile. DIPEA (0.034 mL, 0.198 mmol, 3 eq) was added followed by 6-(piperidin-1-yl)nicotinic acid (0.013 g, 0.066 mmol, 1 eq), EDCI (0.018 g, 0.099 mmol, 1.5 eq) and HOBT (0.013 g, 0.099 mmol, 1.5 eq). The reaction mixture was stirred at ambient temperature for 12 h and concentrated to remove the volatiles. The residue obtained was dissolved in ethyl acetate. The organic layer was washed with water, dried over anhydrous Na2SO4 and concentrated under reduced pressure. The residue was purified by preparative HPLC to afford the title compound (0.03 g, 60%). 1H NMR (400 MHz, DMSO-d6) δ 0.74 (t, 6H), 1.50-1.59 (m, 6H), 1.9-2.0 (s, 1H), 3.03-3.04 (t, 2H), 3.54-3.55 (t, 4H), 4.45-4.49 (m, 6H), 6.82-6.84 (d, 1H), 6.9 (t, 1H), 7.03-7.05 (m, 2H), 7.14-7.28 (m, 6H), 7.42-7.44 (d, 2H), 7.53-7.61 (m, 4H), 7.80 (s, 1H), 8.12 (s, 1H). MS (ESI): 788.6 (M−H)−.

後処理

  1. concentrationconcentrated
  2. customto remove the volatiles
  3. customThe residue obtained
  4. washThe organic layer was washed with water
  5. dry with materialdried over anhydrous Na2SO4
  6. concentrationconcentrated under reduced pressure
  7. customThe residue was purified by preparative HPLC

出典と根拠

ORDレコード
ord-733370a92a36455abaeab73190dd06e8
出典データセット
uspto-grants-2013_08
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08501992B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート